Described is a method of stimulating airways of a mammal comprising: cyclically occluding a nasal air stream at a frequency rate between 50 Hz to 650 Hz. Also described is an apparatus for stimulating airways of a mammal, comprising: a fluid connection to each of a first and second naris of the mammal; and an occluding device configured to cyclically occlude a nasal air stream within each fluid connection at a frequency rate between 100 Hz to 650 Hz.

A device to protect a user from inhaling hazardous atmospheres including an insulated chamber having inlet and outlet. The chamber includes air heating means and air UV radiating means. The combined operation of the air heating means and the UV radiating means is configured for disinfecting the hazardous atmospheres. A cooling means is used for cooling the disinfected hazardous atmospheres. Wherein, the cooled disinfected hazardous atmosphere is then delivered to the user's breathing system.

The present system (10) comprises a subject interface (22), a segmenter (12), a loosener (14), sensors (18), and computer processors (28). The segmenter is configured to selectively control gas flow through the subject interface to provide high amplitude pressure oscillations (44) during exhalation such that the high amplitude pressure oscillations aid cough productivity in the subject. The loosener controls gas flow through the subject interface to provide low amplitude pressure oscillations (43, 63) during inhalation (48, 68) and exhalation (49) such that the low amplitude pressure oscillations loosen respiratory secretions. The computer processors detect trigger events based on the output signals such that the one or more trigger events include a loosening trigger event and a segmenting trigger event (66); and responsive to detecting the loosening trigger event, control the loosener to provide the low amplitude pressure oscillations, and, responsive to detecting the segmenting trigger event, control the segmenter to provide the high amplitude pressure oscillations.

Apparatus and methods are disclosed for controlling pressure delivery to a user such as a patient. A flow generator generates an outlet flow at an outlet port for delivery to a patient. At least one sensor measures properties of the flow of gas at the outlet port or being delivered to the patient. A controller is operatively connected to the flow generator and the at least one sensor, and is adapted to operate according to a pressure control mode in which the controller controls the flow generator to output a substantially steady pressure or a flow control mode in which the controller controls the flow generator to output a substantially steady flow. The controller operates in the flow control mode when a patient may be awake and in the pressure control mode when the patient may be asleep.

Devices for delivering a controlled concentration of an agent are provided. The device includes a reservoir for the agent and a flow control portion operably connected to the reservoir. The device also includes a valve for releasing the agent from the flow control portion and a pump for flowing air to mix with the agent released by the valve and for flowing the agent and air mixture out of the device. Methods of delivering a vaporized agent to a subject are also provided. The methods include storing a liquid agent in a reservoir of a device and flowing the agent into a flow control chamber to change the agent to a gas. The methods also include mixing the agent in gas form with air and flowing the agent and air mixture out of the device to be delivered to a subject.

Apparatus and methods for providing extracorporeal blood circulation and oxygenation control include seven-stage de-airing of blood to provide automated cardiopulmonary replacement to sustain patient life during a medical procedure comprising repairing or replacing the heart valve in a patient.

Pressure support therapy is provided to a subject. The effectiveness of the provided pressure support therapy is determined and/or the therapy is titrated based on determinations of the concentration of one or more gaseous molecular species in gas exhaled by the subject. The determinations of composition of gas exhaled by the subject are obtained from samples with relatively little distortion caused by dilution of expired gases from gases provided to the airway of the subject as part of the pressure support therapy.

The present invention includes a device for hypoxia training comprising: one or more electrochemical cells each comprising: a cathode and an anode separated by a proton exchange membrane, each of the anode and cathode in communication with an input and an output, wherein the input of the cathode is in fluid communication with ambient air, and wherein the input of the anode is in fluid communication with a source of liquid water; a power supply connected to the one or more electrochemical cells; and a mask in fluid communication with the output from the cathode of the one or more electrochemical cells, wherein oxygen is removed from the ambient air during contact with the cathode when hydrogen ions separated from liquid water by a catalyst on the anode convert oxygen in the ambient air into water.

A method for estimating an inhale dose when a drug is delivered to a person using an inhaler is disclosed. A predicted inhale dose (PID) of the drug is estimated based on at least one first-type parameter and at least one second-type parameter. The first-type parameter is related to a breath pattern of the person, and the second-type parameter is related to the inhaler.

An aerosol provision system comprises a heating element for generating an aerosol from a source liquid and control circuitry for controlling a supply of electrical power from a power supply to the heating element. The control circuitry is configured to measure an indication of a derivative of an electrical characteristic of the heating element with respect to time. Based on the measured time derivative, the control circuitry is configured to determine whether or not a fault condition has arisen for the electronic aerosol provision system. The overall change in the electrical characteristic for the heating element caused by the localized heating may be small and so difficult to reliably identify, but the rate at which the change occurs can be expected to be relatively high, such that the time derivative of the local characteristic is a more reliable indicator of occurrence of the fault condition.